Leverkusen, Germany

Clemens Bothe

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovator Clemens Bothe: A Journey Through Pharmaceutical Advancements

Introduction: Clemens Bothe, an accomplished inventor based in Leverkusen, Germany, has made significant contributions to the field of pharmaceuticals. With three patents to his name, Bothe's work focuses on innovative processes and compounds that address critical health challenges, particularly in treating cardiopulmonary diseases.

Latest Patents: Clemens Bothe holds several notable patents, the most recent being a process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as a pharmaceutically active compound. This invention details an advanced method for synthesizing novel crystalline forms, crucial for enhancing the efficacy of treatments for pulmonary and cardiovascular diseases. Additionally, it outlines a selective crystallization process for the pseudopolymorphic forms of the compound, facilitating improved treatment options for various cardiopulmonary disorders.

Career Highlights: Bothe's professional journey includes significant tenures at Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His academic and practical expertise in pharmaceuticals has paved the way for innovative approaches in drug development and formulation. His inventions have been instrumental in providing new solutions for previously challenging medical conditions.

Collaborations: Throughout his career, Clemens Bothe has collaborated with accomplished professionals, including Britta Olenik and Birgit Keil. These partnerships have fostered a collaborative environment that has driven his innovative thinking and contributed to advancements in pharmaceutical science.

Conclusion: Clemens Bothe exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to developing groundbreaking treatments for cardiopulmonary diseases showcases his commitment to improving patient outcomes. With his continued efforts and contributions, Bothe remains a valuable asset to the field of medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…